Apr 6, 2026
Unexpected findings on lung cancer CT scans may point to other non-lung cancers, study finds“Because CT scans capture areas of the body beyond the lungs, doctors often see abnormalities that might indicate cancer in other parts of the body, including the kidneys,...
Mar 30, 2026
Next-generation therapies to outsmart drug-resistant lung cancer“The Gray Lab is developing next-gen therapies, including protein degraders and “dual-grip” inhibitors, to overcome drug resistance in lung cancer.” PFOS, PFHA, Mono-Iso-Nonyl-Phthalate Can...
Mar 23, 2026
Early diagnosis and local solutions are critical to combat lung cancer“Opinion: Despite advances in prevention and treatment, lung cancer remains the world’s deadliest cancer largely because it is often detected too late. Strengthening local diagnostic capacity is one...
Mar 16, 2026
Why lung cancer belongs in the women’s health conversation“Cancer mortality in the United States has steadily declined for more than three decades, with millions of lives saved through smoking cessation, earlier detection, and improved treatment. But the epidemiology...
Mar 2, 2026
Gaps in Lung Cancer Treatment Persist, Yale Study Finds“In recent decades, lung cancer treatment has been transformed—new surgeries, new radiation techniques, and dramatically improved outcomes. But according to new research from Yale, published in JAMA Network Open,...
Feb 24, 2026
FDA Approves Monthly Dosing for Subcutaneous Amivantamab in EGFR-Mutated NSCLC“The U.S. Food and Drug Administration has approved a once-monthly dosing schedule for frontline amivantamab and hyaluronidase-lpuj (Rybrevant Faspro), the subcutaneous formulation of the...
